You must select a location to proceed.
There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.
Adding Registration, Please wait...
You must be logged in to perform this action.
How to Talk to Patients About Opioids
Release Date (enduring material): June 30, 2021
Expiration date: June 30, 2024
This on-demand course has been approved by the Wisconsin Medical Examining Board as meeting the requirements for the two-hour continuing education course on responsible opioid prescribing per Med 13.03(3) of the Wisconsin Administrative Code.
This activity has been pre-approved for ABIM, ABA, ABP, ABOHNS, ABO, and ABPath MOC Part II credit. Approval for MOC Part II credit by other ABMS Boards may be found here. Participants who complete the activity by Dec. 3, 2021, will have their MOC credit submitted for 2021; after Dec. 3, 2021, MOC credits will be submitted for 2022.
Upon completion of this educational activity, learners will be able to demonstrate an understanding of:
- How to help a patient accurately assess the risk/benefits ratio of opioids for treating acute or chronic pain.
- Helping the patient have appropriate expectations about opioid therapy.
- Setting boundaries with opioid-seeking patients and helping them understand why opioids are not in their best interest.
- The use of scripting to maximize the potential for getting patients showing evidence of nascent opioid use disorder the treatment they need to prevent its worsening.
Method of Participation
This activity requires completion of a brief pre-test prior to start time. Please plan accordingly. Participants view the presentation and listen to the synchronized audio of the recorded lecture. After completing the activity, participants must complete an evaluation and a post-test in which they must answer at least 75% of the answers correctly in order to receive AMA PRA Category 1 Credit™. The participant cannot proceed to request credit until this score is achieved.
Michael McNett, MD
E-mail firstname.lastname@example.org for questions related to the educational content.
This activity is designed for Primary Care Physicians, Specialty Physicians, Allied Health Professionals, Nurses, Social Workers, Professional Staff.
No commercial support was used in creating this educational activity.
ADA Compliance Statement
In accordance with the Americans with Disabilities Act, the Wisconsin Medical Society seeks to make this activity accessible to all. If you have a disability, which might require special accommodations, please call 608.442.3800.
Registration is not refundable. If you are unable to participate in an activity for which you are registered, you may have a substitute participate in your place.
The Wisconsin Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Wisconsin Medical Society designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|2 MOC Part II Credit Application for MOC Part II credit has been filed with the American Board of Medical Specialties (ABMS) for approval by ABMS Member Boards. See course description for more information.
|2 AMA PRA Category 1 Credit(s)™ (Enduring) The Wisconsin Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Wisconsin Medical Society designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Customers Who Bought This Item Also Bought
Effective Pain Management for a Healthier South Carolina: CME on Acute Pain, Chronic Pain, and Opioid Misuse/Opioid Use Disorder
6th Edition - Approved Procedures for South Carolina Physicians Prescribing and Monitoring Controlled Substance